Have you heard the news? The FDA has blocked providing federal monoclonal antibodies to the State of Florida.
Monoclonal antibodies are just like your body’s antibodies that have a strong ability to resist viruses. They are produced like a medication to help your body fight illness.
In 2020, the American FDA issued an emergency use authorization to permit monoclonal antibodies as a treatment for COVID-19.
Today, they are blocking their use, and not because they don’t work – nope – monoclonal antibodies are among the most promising treatments for mild to moderate COVID-19 caused by the coronavirus SARS-CoV-2 and its variants.
So, what’s going on?
The Brilliance Of Antibodies
Antibodies are proteins made by your body’s immune system that fight off infections, including infections caused by viruses. Your body can remember how to make antibodies if you are exposed to the same germ again.
Antibodies work, and if they work for one virus, they work on any of them. Your body doesn’t know the difference – an invader is an invader, especially if it’s seen it before.
No More For You
So why would the Federal government stop providing them for people to try? If they work, they work. If they don’t, they don’t, but taking them does no harm.
If you know anyone who used them when they were sick with COVID, they’ll tell you that they recovered in 36 hours after taking the monoclonal antibodies.
So let me ask you again … why would the Federal government stop providing them for people to try?
Not too long ago after the Biden Administration announced that it would be halting distribution of Regeneron and Eli Lilly monoclonal antibody treatments to US states, they reversed the decision due to pushback, allowing states to continue to order these treatments through the allocation system.
However, Florida is using at least 30,000 more doses per week than it is receiving through the government allocation system to expand capacity at existing monoclonal antibody treatment sites and to open new sites.
Here’s another great question: why did the Federal government take over the monoclonal market?
Instead of allowing other states to follow Florida’s lead in providing this treatment to their citizens, the Biden Administration decided to take full control of the supply of monoclonals, and then they dramatically cut Florida’s supply. To help fill the gap caused by this cut in allocation, Florida worked with GlaxoSmithKline to bring thousands of doses of another monoclonal to Florida, but the Biden Administration took control of this treatment as well.
Why?
Unless the Biden Administration shuts this down, too, currently the FDEM (Florida Department of Emergency Management) has more than $800 million in monoclonal antibodies remaining and available to quickly deploy treatments throughout the state while Florida waits to be permitted to directly purchase the monoclonal antibody treatments from the distributor.
Do No Harm
Let me leave you with this: monoclonal antibodies do no harm, and they are saving lives and keeping people out of the hospitals. Why would ANYONE block the use of this treatment for people who are sick and in need?
________________
If you want to learn more about healthy living, contact me at janethull.com. Remember that you are never alone when you are looking for good health!
_____________
Disclaimer: This article is for informational purposes only, and is educational in nature. The FDA may not have evaluated some of the statements. This article is not intended to diagnose, treat, cure, or prevent any disease. Please discuss with your own, qualified health care provider before adding supplements or making any changes to your dietary program.
Before taking vitamins, consult your doctor; pre-existing medical conditions or medications you are taking can affect how your body responds to multivitamins.
You have our permission to reprint this article if you attribute us with a live back-link to this article and the youtube links. https://janethull.com/
